Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The overall objective of this study is to evaluate the safety and diagnostic efficacy of
Mangoral in liver MRI in participants with known or suspected focal liver lesions and severe
renal impairment. The diagnostic efficacy of Mangoral will be assessed in terms of
visualization of detected focal liver lesions in combined MRI (CMRI: combined
Mangoral-enhanced and unenhanced MRI) compared to unenhanced MRI.